The University of Utah College of Pharmacy is part of the University of Utah Health Sciences Center, with state-of-the-art classroom, research and library facilities available to students pursuing graduate education. The Department of Pharmacotherapy has a long, rich history in the provision of high quality post-graduate training for pharmacy practitioners and outcomes researchers. Students in the Doctor of Philosophy in Pharmacotherapy Outcomes Research Program are highly motivated with backgrounds in a pharmacy and pharmaceutical sciences, health economics, or other healthcare field.
Students graduate with core competencies in health economics, epidemiology, research design, and statistics. They are also prepared to be independent outcomes researchers trained to generate evidence to support health policy decisions regarding pharmaceuticals and related technologies. Graduates of our program currently apply these sills in a broad range of career settings including the pharmaceutical industry, academia, institutional pharmacy, community pharmacy, and managed care organizations.
We require a statement of purpose, CV, transcripts, score reports (GRE for US applicants and GRE and TOEFL for International applicants) and three letters of recommendation from all applicants.
Deadlines for 2017-2018 academic year:
December 15, 2016 Final deadline for International students.
January 10, 2017 Final deadline for US residents.
All individuals wishing to apply to our PhD program, please use the electronic application process called APPLY YOURSELF. The link to this site is below.
The Department of Pharmacotherapy together with the Dean's Office have developed a pathway for students who are interested in simultaneously pursuing a PharmD and a PhD in Pharmacotherapy Outcomes Research & Health Policy. This program is intended for students who are interested in a career in outcomes research applied to informed decisions of providers, patients and payers regarding new pharmaceutical therapies and associated technologies. It is constructed to intersperse the core curriculum requirements of the PhD program into the curriculum of the PharmD program, making course substitutions where feasible. In doing this, we minimize curriculum redundancy between the two programs while ensuring that the student is adequately prepared for the demands of both degree programs.
During the joint program pathway, students undertake research in the summers between their P1-P3 years. Students are also expected to use at least one clerkship rotation for research. The program is structured so that students can take their PhD qualification exams during their P5 year and their pharmacy licensure exam at the normal time after completion of the P4 year. Following P4 year, the students engage in full time research to complete the PhD program.
Students who are interested in pursuing this pathway should apply to the PharmD program first. Students are accepted into the PhD program during their P1 year if the student meets the program admissions criteria and there is appropriate research mentoring and support for the student. Interested students should contact the Director of Graduate Studies or the Administrative Officer in the Department of Pharmacotherapy for application procedures and information. Students enter directly into the PharmD/PhD program. Curriculum based on application to the Pharmacotherapy program during the P1 year. First class would be summer rotations.
Director of Graduate Studies